SCHEMBL13645570

SCHEMBL13645570

Cc1ccsc1C(=O)Nc1ccccc1CC[Si](C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.52
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPC1 O15118 9/20 0.48
RAB9A P51151 9/20 0.48
PPARG P37231 1/20 0.48
NCOR2 Q9Y618 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
NAMPT P43490 1/20 0.47
POLB P06746 1/20 0.46
PKM P14618 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13645578 0.88 ALDH1A1 (0.44) KMT2ANPC1RAB9APPARGNCOR2
SCHEMBL4669956 0.82 HPGD (0.50) KMT2AHPGDSMN1; SMN2NPC1RAB9A
SCHEMBL13292708 0.80 ALDH1A1 (0.44) KMT2AHPGDSMN1; SMN2RAB9APPARG
SCHEMBL9259634 0.78 HPGD (0.63) KMT2AHPGDSMN1; SMN2NPC1RAB9A
SCHEMBL4860405 0.76 SMN1; SMN2 (0.60) KMT2AHPGDSMN1; SMN2NPC1RAB9A
SCHEMBL13645619 0.74 MAPK1 (0.69) KMT2AHPGDSMN1; SMN2NPC1RAB9A
SCHEMBL4818422 0.74 SMN1; SMN2 (0.58) KMT2AHPGDSMN1; SMN2NPC1RAB9A
SCHEMBL13645618 0.74 KMT2A (0.49) KMT2AMEN1
SCHEMBL6018780 0.73 SMN1; SMN2 (0.57) KMT2AHPGDSMN1; SMN2NPC1RAB9A
SCHEMBL3863550 0.73 SMN1; SMN2 (0.57) KMT2AHPGDSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598389-B2 Silylated carboxamides BAYER CROPSCIENCE AG (DE) 2009-10-06 US disclosed
US-20070191454-A1 Silylated carboxamides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191454-A1 Silylated carboxamides MRPL21, MRPS22, MRPS34 KMT2A 707/4885HPGD 4402/4885SMN1; SMN2 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.